Velagapudi Mary E, Navarro Juliana J, Hill Alexander E, Darracq Michael A, Thornton Stephen L
Department of Emergency Medicine University of Kansas Health System Kansas City Kansas USA.
Department of Emergency Medicine University of California San Francisco-Fresno California USA.
J Am Coll Emerg Physicians Open. 2024 Oct 3;5(5):e13296. doi: 10.1002/emp2.13296. eCollection 2024 Oct.
North American coral snake envenomations can result in life-threatening neurotoxicity. Their bites are relatively rare, making large studies difficult. Using the National Poison Data System (NPDS), we sought to investigate the epidemiological trends and clinical outcomes associated with North American coral snake bites over a 17-year period.
NPDS cases involving coral snakes from January 1, 2006, to December 31, 2022, were analyzed. Data collected included patient age, date, geographic location, clinical effects, treatments administered, and medical outcomes including incidence of "dry bites" (non-envenomation) and death.
During the 17-year period, a total of 1374 cases were reported and analyzed. Cases included adults (≥ 20 years), accounting for 80% ( = 1107), and pediatric patients (≤19 years), accounting for 20% ( = 267) of total cases. Out of 50 US states and District of Columbia, 20 states reported cases. Florida and Texas accounted for 90.5% of all bites ( = 1243) with April being the month with the most reported cases ( = 184). The most bites ( = 96) were reported in 2008 and the fewest ( = 69) in 2016. Male patients predominated for both pediatric (75.7%, = 202) and adult cases (75.3%, = 834). Moderate to major clinical outcomes were documented in approximately 30% of total cases; with no reported deaths. Moderate effect is defined as the patient exhibited symptoms as a result of the exposure that were more pronounced, more prolonged, or more of a systemic nature than minor symptoms. Major effect was defined as the patient exhibited symptoms as a result of the exposure that were life threatening or resulted in significant residual disability or disfigurement. The three most reported clinical effects were wound/sting, dermal irritation/pain, and edema. Antivenom was administered in 21% ( = 286) of total cases and 37% ( = 511) of patients were admitted to a critical care unit. Dry bites occurred in 7% ( = 100) of total cases.
Coral snake bites were rare, but consistently reported. While bites were associated with significant morbidity in adult and pediatric patients, there were no deaths reported. Antivenom use declined over the study period but was not associated with an increase in morbidity. An increased incidence of intubations was seen in association with decreased antivenom use.
北美珊瑚蛇咬伤可导致危及生命的神经毒性。其咬伤相对罕见,使得大规模研究困难重重。我们利用国家毒物数据系统(NPDS),试图调查17年间北美珊瑚蛇咬伤的流行病学趋势及临床结局。
对2006年1月1日至2022年12月31日涉及珊瑚蛇咬伤的NPDS病例进行分析。收集的数据包括患者年龄、日期、地理位置、临床症状、所采取的治疗措施以及医疗结局,包括“干咬”(未注入毒液)和死亡的发生率。
在这17年期间,共报告并分析了1374例病例。病例包括成人(≥20岁),占总病例数的80%(n = 1107),以及儿科患者(≤19岁),占总病例数的20%(n = 267)。在美国50个州和哥伦比亚特区中,有20个州报告了病例。佛罗里达州和得克萨斯州占所有咬伤病例的90.5%(n = 1243),4月是报告病例最多的月份(n = 184)。2008年报告的咬伤病例最多(n = 96),2016年最少(n = 69)。儿科患者(75.7%,n = 202)和成人病例(75.3%,n = 834)中男性患者居多。约30%的总病例记录了中度至重度临床结局;无死亡报告。中度效应定义为患者因接触而出现的症状比轻度症状更明显、持续时间更长或具有更明显的全身性。重度效应定义为患者因接触而出现的症状危及生命或导致严重的残留残疾或毁容。报告最多的三种临床症状是伤口/蜇伤、皮肤刺激/疼痛和水肿。21%(n = 286)的总病例使用了抗蛇毒血清,37%(n = 511)的患者被收入重症监护病房。干咬发生在7%(n = 100)的总病例中。
珊瑚蛇咬伤罕见,但报告持续存在。虽然咬伤在成人和儿科患者中都与显著的发病率相关,但未报告死亡病例。在研究期间,抗蛇毒血清的使用有所下降,但与发病率的增加无关。随着抗蛇毒血清使用的减少,插管发生率有所增加。